BioLineRx (BLRX) Institutional Ownership $5.82 -0.11 (-1.85%) Closing price 06/10/2025 04:00 PM EasternExtended Trading$5.67 -0.15 (-2.58%) As of 04:48 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for BioLineRx (NASDAQ:BLRX)CurrentInstitutional OwnershipPercentage1.56%Number ofInstitutional Buyers(last 12 months)4TotalInstitutional Inflows(last 12 months)$30.68MNumber ofInstitutional Sellers(last 12 months)0 Get BLRX Insider Trade Alerts Want to know when executives and insiders are buying or selling BioLineRx stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data BLRX Institutional Buying and Selling by Quarter BioLineRx Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails2/12/2025 Highbridge Capital Management LLC1,010,012$215K0.0%N/A50.501% 11/1/2024 Atria Investments Inc133,974$72K0.0%+27.9%0.168% 8/22/2024 PVG Asset Management Corp123,580$70K0.3%N/A0.155% 8/15/2024CVI Holdings LLC815,683$462K0.4%N/A1.020% 3/12/2024 PVG Asset Management Corp61,840$97K0.5%N/A0.085% 2/8/2024 NorthRock Partners LLC17,125$27K0.0%N/A0.024% 12/1/2023B. Riley Wealth Advisors Inc.21,300$39K0.0%+88.5%0.029% 11/21/2023 Allen Mooney & Barnes Investment Advisors LLC25,000$46K0.0%N/A0.035% 11/13/2023 Rathbones Group PLC39,820$72K0.0%N/A0.065% 11/8/2023 Values First Advisors Inc.48,348$88K0.1%N/A0.079% Get the Latest News and Ratings for BLRX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for BioLineRx and its competitors with MarketBeat's FREE daily newsletter. 10/11/2023 Geneos Wealth Management Inc.40,500$74K0.0%+72.3%0.066% 7/31/2023 PVG Asset Management Corp61,840$99K0.4%-52.0%0.101% 5/16/2023 Altium Capital Management LP2,279,657$2.02M1.1%-26.5%3.705% 11/14/2022 Armistice Capital LLC2,797,048$2.59M0.0%N/A4.546% 11/14/2022 Altium Capital Management LP4,149,262$3.84M1.4%N/A6.744% 11/8/2022 Apollon Wealth Management LLC48,790$45K0.0%N/A0.079% 11/7/2022 Virtu Financial LLC46,168$43K0.0%+195.6%0.075% 10/13/2022 PVG Asset Management Corp47,860$44K0.2%N/A0.100% 7/22/2022 Geneos Wealth Management Inc.41,450$53K0.0%+25.8%0.087% 5/13/2022 Parkman Healthcare Partners LLC270,665$463K0.1%-36.9%0.568% 2/9/2022 Geneos Wealth Management Inc.28,950$59K0.0%+63.1%0.061% 2/4/2022 Envestnet Asset Management Inc.122,224$249K0.0%+184.7%0.256% 2/2/2022 PVG Asset Management Corp160,360$327K1.2%+109.6%0.336% 1/28/2022 ARK Investment Management LLC1,059,722$2.16M0.0%-1.3%2.223% 11/16/2021 Schonfeld Strategic Advisors LLC12,100$33K0.0%N/A0.025% 11/16/2021 Intellectus Partners LLC28,500$78K0.0%-29.6%0.060% 11/12/2021 Parkman Healthcare Partners LLC411,060$1.13M0.3%-44.0%0.869% 11/10/2021 PVG Asset Management Corp76,510$210K0.6%N/A0.162% 10/26/2021 Game Plan Financial Advisors LLC25,000$69K0.0%-13.8%0.053% 9/17/2021 Virtu Financial LLC16,578$47K0.0%N/A0.035% 8/13/2021 Renaissance Technologies LLC77,808$219K0.0%-84.6%0.165% 8/11/2021 Susquehanna Fundamental Investments LLC19,026$53K0.0%-74.5%0.040% 8/9/2021 Cutter & CO Brokerage Inc.18,667$52K0.0%-34.9%0.039% 5/18/2021 Morgan Stanley398,412$1.11M0.0%-45.6%0.875% 5/18/2021 First Heartland Consultants Inc.10,000$28K0.0%N/A0.023% 5/18/2021 Silverarc Capital Management LLC200,000$558K0.3%N/A0.465% 5/17/2021 Schonfeld Strategic Advisors LLC76,500$213K0.0%+115.5%0.178% 5/17/2021 Intellectus Partners LLC40,500$113K0.0%N/A0.094% 5/17/2021 Goldman Sachs Group Inc.16,621$46K0.0%N/A0.039% 5/13/2021 Renaissance Technologies LLC505,121$1.41M0.0%+89.2%1.174% Banks aren’t ready for this altcoin—are you? (Ad)While everyone's distracted by Bitcoin's moves, a stealth revolution is underway. One altcoin is quietly positioning itself to overthrow the entire banking system.Click here to access the full report now.(Data available from 1/1/2016 forward) BLRX Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of BLRX shares? During the previous two years, 10 institutional investors and hedge funds held shares of BioLineRx. The most heavily invested institutionals were CVI Holdings LLC ($462K), Highbridge Capital Management LLC ($215K), Values First Advisors Inc. ($88K), Geneos Wealth Management Inc. ($74K), Atria Investments Inc ($72K), Rathbones Group PLC ($72K), and PVG Asset Management Corp ($70K).Learn more on BLRX's institutional investors. What percentage of BioLineRx stock is owned by institutional investors? 1.56% of BioLineRx stock is owned by institutional investors. Learn more on BLRX's institutional investor holdings. Which institutional investors have been buying BioLineRx stock? Of the 10 institutional investors that purchased BioLineRx stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Highbridge Capital Management LLC ($1.01M), CVI Holdings LLC ($815.68K), PVG Asset Management Corp ($185.42K), Values First Advisors Inc. ($48.35K), Rathbones Group PLC ($39.82K), Atria Investments Inc ($29.19K), and Allen Mooney & Barnes Investment Advisors LLC ($25K). How much institutional buying is happening at BioLineRx? Institutional investors have bought a total of 2,197,601 shares in the last 24 months. This purchase volume represents approximately $45.85M in transactions. Which BioLineRx major shareholders have been selling company stock? The following institutional investors have sold BioLineRx stock in the last 24 months: PVG Asset Management Corp ($66.89K). How much institutional selling is happening at BioLineRx? Institutional investors have sold a total of 66,885 shares in the last 24 months. This volume of shares sold represents approximately $4.27M in transactions. Related Companies FBRX Institutional Ownership PDSB Institutional Ownership IMRX Institutional Ownership ELUT Institutional Ownership IGMS Institutional Ownership ABOS Institutional Ownership EPIX Institutional Ownership SRZN Institutional Ownership ADAP Institutional Ownership GNTA Institutional Ownership This page (NASDAQ:BLRX) was last updated on 6/11/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BioLineRx Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share BioLineRx With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
